Medicinal – mycolab.ai

Corrigendum: Inonotus obliquus (chaga) ameliorates folic acid-induced renal fibrosis in mice: the crosstalk analysis among PT cells, macrophages and T cells based on single-cell sequencing

mycolabadmin

This research article, published as a correction, examines how chaga mushroom (Inonotus obliquus) may help treat kidney fibrosis in mice. Using advanced genetic sequencing technology that examines individual cells, scientists identified how chaga works by modulating communication between different immune and kidney cells. The findings suggest that chaga could be a promising natural treatment for progressive kidney disease.

Natural Compounds of Fungal Origin with Antimicrobial Activity—Potential Cosmetics Applications

mycolabadmin

Fungi naturally produce many compounds that kill harmful bacteria, fungi, and viruses. This review explores how these fungal compounds could replace antibiotics that no longer work due to drug resistance. These natural substances could be used not only as medicines but also in cosmetic products to prevent bacterial growth and improve skin health.

Seaweed Protein Hydrolyzates: A Valuable Source of Short- and Medium-Chain Peptides with Multifunctional Properties

mycolabadmin

Scientists found that an invasive seaweed species can be converted into health-promoting peptides (small protein fragments) that may help control blood pressure and blood sugar levels. The study identified hundreds of these peptides and tested their effectiveness against enzymes involved in hypertension and diabetes. The peptides showed promise as natural ingredients for functional foods designed to prevent metabolic diseases while also addressing the environmental problem of harmful seaweed blooms.

Key sugar transporters drive development and pathogenicity in Aspergillus flavus

mycolabadmin

Researchers studied how Aspergillus flavus fungus transports sugars, which is crucial for its growth, producing the toxic aflatoxin that contaminates crops like corn and peanuts. By removing genes responsible for sugar transport, they found that the fungus became weak, couldn’t infect plants or animals effectively, and stopped producing the dangerous aflatoxin. This discovery could help develop new strategies to prevent aflatoxin contamination in food and reduce serious fungal infections in humans.

Multidisciplinary Integrative Medicine Approach for Cancer Patients: A Multicenter Retrospective Study

mycolabadmin

This study shows that when cancer patients use complementary treatments like mushroom supplements, vitamins, and probiotics alongside their cancer medications under doctor supervision, they experience fewer side effects and better quality of life. Almost 93% of patients had no side effects from these supplements, and many reported less fatigue and better overall wellness. The key finding is that patients should work with their medical team rather than self-prescribing these treatments to avoid dangerous interactions.

Drug–drug interactions involving classic psychedelics: A systematic review

mycolabadmin

This review examined how psychedelic drugs like LSD and psilocybin interact with other medications people might be taking. Researchers found that certain psychiatric medications like antipsychotics can block the effects of psychedelics, while other drugs may enhance them. The study highlights the importance of understanding these interactions for safe therapeutic use of psychedelics in clinical settings.

Comparative study on structural characterization, physicochemical properties, and in vitro probiotic activities of resistant starch from different varieties of Euryale ferox

mycolabadmin

Euryale ferox, a nutritious aquatic plant, contains two varieties with significantly different health benefits. North Euryale ferox has much higher levels of resistant starch (a special type of starch that resists digestion) compared to South Euryale ferox, making it potentially more beneficial for gut health and diabetes management. The resistant starch in this plant acts as a prebiotic, promoting the growth of beneficial gut bacteria while inhibiting harmful bacteria, supporting overall digestive and metabolic health.

New perspective on sustained antidepressant effect: focus on neurexins regulating synaptic plasticity

mycolabadmin

This review explores how hallucinogens like ketamine and psilocybin produce long-lasting antidepressant effects by changing how brain cells communicate. The key mechanism involves special molecules called neurexins that sit at the connections between neurons and control whether those connections strengthen or weaken. By understanding and potentially targeting neurexins, scientists hope to develop new depression treatments that work longer and more effectively than current medications.

Microbiota-based interventions for autism spectrum disorder: a systematic review of efficacy and clinical potential

mycolabadmin

This comprehensive review examines how modifications to gut bacteria through probiotics, prebiotics, synbiotics, and fecal transplants can help children with autism. The research found that while all these treatments showed some promise, fecal microbiota transplantation (FMT) produced the most consistent improvements in both autism-related behaviors and digestive symptoms. These microbiota-based approaches work through the gut-brain connection and were generally safe, making them potentially valuable additions to autism management strategies.

Overcoming Solubility Challenges: Micronization of Berberine Using the GAS Antisolvent Technique

mycolabadmin

Berberine is a traditional medicinal compound that could treat many diseases but doesn’t work well in the body because it doesn’t dissolve in water. Researchers used a special technique with pressurized carbon dioxide to break berberine into much smaller particles. This made the particles dissolve 18% better in water, which could make berberine-based medicines more effective at treating diabetes, high cholesterol, and other conditions.

Research Topic: Medicinal